Article citationsMore>>

Terauchi, Y., Fujiwara, H., Kurihara, Y., Suganami, H., Tamura, M., Senda, M., et al. (2019) Long-Term Safety and Efficacy of the Sodium-Glucose Cotransporter 2 Inhibitor, Tofogliflozin, Added on Glucagon-Like Peptide-1 Receptor Agonist in Japanese Patients with Type 2 Diabetes Mellitus: A 52-Week Open-Label, Multicenter, Post-Marketing Clinical Study. Journal of Diabetes Investigation, 10, 1518-1526.
https://doi.org/10.1111/jdi.13066

has been cited by the following article:

Follow SCIRP
Twitter Facebook Linkedin Weibo
Contact us
+1 323-425-8868
customer@scirp.org
WhatsApp +86 18163351462(WhatsApp)
Click here to send a message to me 1655362766
Paper Publishing WeChat
Free SCIRP Newsletters
Copyright © 2006-2024 Scientific Research Publishing Inc. All Rights Reserved.
Top